Human metabolism and excretion kinetics of benzotriazole UV stabilizer UV-327 after single oral administration.
Journal Information
Full Title: Arch Toxicol
Abbreviation: Arch Toxicol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Conflict of interestE. Leibold is employed by BASF SE, a former manufacturer of UV-327; however, BASF SE was not involved in the study design nor in the evaluation or interpretation of the results. C. Fischer, J. Hiller, and T. Göen have no conflicts of interest to declare. Ethics approvalThe study has been approved by the ethics committee of the medical faculty of Friedrich-Alexander-Universität Erlangen-Nürnberg (49_18 B) and has been performed in accordance with all relevant ethical standards. All study participants gave their written and informed consent to participate in the study. Conflict of interest E. Leibold is employed by BASF SE, a former manufacturer of UV-327; however, BASF SE was not involved in the study design nor in the evaluation or interpretation of the results. C. Fischer, J. Hiller, and T. Göen have no conflicts of interest to declare."
"Funding Open Access funding enabled and organized by Projekt DEAL. Method development was financed by Chemie Wirtschaftsförderungsgesellschaft mbH."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025